Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04404842
Other study ID # 14052020
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 14, 2020
Est. completion date January 31, 2022

Study information

Verified date May 2020
Source University of Pavia
Contact Chiara Elena Tomasinelli
Phone +39 0382 987536
Email chiara.tomasinelli@unipv.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Since vitamin D deficiency is a condition that affects a high percentage of individuals of all ages and given the attention on the possible role of the deficiency of this vitamin in the development of various chronic diseases, including cardiovascular and metabolic disease (obesity, insulin resistance, hypertension, diabetes) and the correlation with mortality from major cardiovascular events (heart failure, myocardial infarction, sudden cardiac death, stroke, atrial fibrillation and peripheral vascular disease), it is clear that in clinical practice it is necessary to provide screening tools characterized by a simple use, high efficacy and a low economic impact, useful to detect a possible deficiency state that has a significant impact on general health and therefore provide targeted interventions for diagnosis and supplementation when and if necessary. Therefore, the objective of this study project is part of the broader context of supporting, with reproducible and shared scientific data, operational protocols useful for the clinician to identify subjects potentially at risk of vitamin D deficiency as well as directing to the diagnostic and more effective therapeutic. Surveillance of vitamin D status should be a high priority in which easy-to-use and interpreted tools, such as the questionnaire developed for this study, could respond to the needs of early identification of subjects potentially at risk of hypovitaminosis D, thus supporting the work of the clinician.


Description:

It will be administered the questionnaire which includes specific and previously identified questions useful for the purpose of the study to all patients who belong to the clinic of the Dietetics and Clinical Nutrition, Internal Medicine and Endocrinology Unit, ICS Maugeri di Pavia who meet the inclusion criteria and signed the Informed Consent. The blood dosage of 25 (OH) D will be used as a reference standard useful for achieving the purpose of the study subject to the execution of diagnostic-therapeutic procedures that are beneficial to the patient or performed for routine diagnostic procedures or previously prescribed by the general practitioner. The collected data will be entered in the Data Collected Form together with the laboratory tests.

Therefore, all patients will receive the EVIDENCE Questionnaire which includes 19 items that investigate those factors that influence the production, absorption and intake of vitamin D:

- anthropometric data (weight, height, waist circumference, BMI),

- demographic information, such as latitude and phototype,

- dietary intake of vitamin D,

- health status and therapies,

- multivitamin or vitamin D supplementation,

- sun exposure habits according to the season, frequency and time of exposure, the body parts exposed, the sunscreens use and outdoor activities.

The aim of the study is to develop a questionnaire useful in screening the adequacy of vitamin D concentration in the adult population and to produce evidence of construct validity and concurrent validity of the questionnaire itself.

SAMPLE SIZE: Psychometric literature suggests enrolling around 5-10 subjects for each item. Considering the number of items in the questionnaire, equal to 19, the number of subjects to be enrolled will be approximately 190.


Recruitment information / eligibility

Status Recruiting
Enrollment 190
Est. completion date January 31, 2022
Est. primary completion date January 31, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects older than or equal 18 years;

- Absence of liver pathologies;

- Absence of kidney pathologies;

- Absence of intestinal malabsorption syndromes;

- Absence of bariatric surgery;

- Absence of cancer;

- Absence of primary hyperparathyroidism;

- Absence of extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis, vitiligo)

- Absence of supplementation with multivitamin supplements or vitamin D;

- Absence of chronic drug therapy with: anticonvulsants, antipsychotics, glucocorticoids, immunosuppressive corticosteroids, anti-retrovirals, slimming, hypocolestrolemicants, laxatives (prolonged use);

- acceptance and sign of informed consent.

Exclusion Criteria:

- Subjects under 18 years old;

- Affected by liver pathologies;

- Affected by kidney pathologies;

- Affected by intestinal malabsorption syndromes;

- Affected by cancer;

- Affected by primary hyperparathyroidism;

- Affected by extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis, vitiligo).

- Candidates and/or undergoing bariatric surgery;

- Supplementation with multivitamin or vitamin D;

- Chronic therapy with: anticonvulsants, antipsychotics, glucocorticoids, immunosuppressive corticosteroids, anti-retrovirals, slimming, hypocolestrolemizzanti, laxatives (prolonged use).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Istituti Clinici Scientifici Maugeri SpA Pavia Lombardia

Sponsors (2)

Lead Sponsor Collaborator
University of Pavia Istituti Clinici Scientifici Maugeri SpA

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Construct validity (EVIDENCE Questionnaire) The construct validity of the questionnaire will be assessed using exploratory factorial analysis. 1 hour
Primary Internal consistency (EVIDENCE Questionnaire) The internal consistency will be evaluated with the Cronbach alpha coefficient or with the McDonald Omega coefficient. 1 hour
Primary Concurrent validity (EVIDENCE Questionnaire) The concurrent validity will be assessed by comparing the results obtained with the serum 25 (OH) D dosage taken as the reference standard. 1 hour
Primary Questionnaire Scoring Determine the optimal cut-off score of EvidenceQ for screening of subjects potentially at risk of vitamin D inadequacy. 1 hour
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Recruiting NCT05459298 - ViDES Trial (Vitamin D Extra Supplementation) N/A
Completed NCT04476511 - The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules Phase 3
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT03920150 - Vitamin D 24'000 IU for Oral Intermittent Supplementation Phase 3
Completed NCT03264625 - The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Phase 2
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Recruiting NCT05084248 - Vitamin D Deficiency in Adults Following a Major Burn Injury Phase 4
Completed NCT05506696 - Vitamin D Supplementation Study N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Completed NCT03234218 - Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
Completed NCT02906319 - Vitamin D and HbA1c Levels in Diabetic Patients With CKD N/A
Completed NCT02714361 - A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women N/A
Completed NCT03203382 - Corneal Nerve Structure in Sjogren's
Completed NCT02118129 - Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'. N/A
Completed NCT02275650 - The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter N/A
Completed NCT02187146 - The Effects of Serum Vitamin D and IVF Outcome N/A
Not yet recruiting NCT01419821 - Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5 N/A
Completed NCT01741181 - Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2 Phase 4
Completed NCT01651000 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3